Avidity Partners's book
15 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Aledade | Enterprise Systems (Healthcare) | $3.5B | — | — | |
| Innovaccer | — | $1.2B | ~$3 | — | |
| Calyxo | — | $684.6M | — | — | |
| Exo | — | $645.0M | — | — | |
| Artios | Drug Discovery | $260.3M | — | — | |
| connectRN | — | $256.0M | — | — | |
| Nested Therapeutics | — | $203.2M | — | — | |
| Affinia Therapeutics | — | $145.0M | — | — | |
| 858 Therapeutics | — | $140.0M | — | — | |
| Sirona | — | $125.0M | — | — | |
| + 5 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 15 recorded positions
- ·Watchlist + alerts for Avidity Partners's activity
Create free account
No card required